Randox Laboratories Ltd.

Randox Laboratories Ltd. is a privately owned diagnostic reagent and equipment manufacturer and the leading British manufacturer of clinical chemistry reagents. Randox has over 25 years experience in research, development, manufacture and marketing of high quality diagnostic reagents and equipment for laboratory medicine.
The Randox portfolio includes the revolutionary Biochip Array Technology for application in genomics and proteomics, clinical chemistry automation systems, external quality assurance schemes, internet driven QC systems, quality control materials, clincial reagents and environmental diagnostics. The life sciences department offers a range of polyclonal antibodies and recombinant proteins, and the customer service team offers an assay development service. Randox is a significant investor in the development of new healthcare technology solutions.
Randox employs over 700 people, including 200 research scientists. Randox's success has been built on our philosophy - "we exist and expand through our customers".
Randox has sales and distribution agreements in 130 countries and international offices worldwide.
Reviews
No reviews to display
Latest Videos
Latest products
The RX monaco is the latest, fully automated, addition to the RX Series of Wine Testing analysers. At optimal configuration the RX monaco is capable ...
More about the RX Monaco Wine Analyzer
The Randox Homocysteine is a liquid stable kit providing a convenient and accurate method for the determination of homocysteine in human serum and ...
More about the Homocysteine
The RX Daytona Plus provides high quality testing on a compact, easy to use clinical chemistry analyzer for accurate results you can trust. The RX ...
More about the Rx Daytona Plus
The RX Daytona is a compact fully automated bench-top clinical chemistry analyzer ideal for use in small to medium throughput laboratories, or as a...
More about the RX Daytona
The Familial Hypercholesterolemia (FH) Array offers rapid and reliable assessment of patients with suspected FH. Utilizing Biochip Array Technology...
More about the Familial Hypercholesterolemia Array
Latest news
News
Randox Licenses sPLA2 CVD Risk Test from Aterovax
01 May 2013
-
Randox Quality Management Solutions
01 Apr 2013
-
Randox Launches Dedicated Liquid BNP Control as Part of the Acclaimed Acusera Range
22 Feb 2013
-
Randox Launches a New Clinical Chemistry Analyzer
05 Dec 2012
-
Randox Announces CE Marking of its Sexually Transmitted Infection (STI) Multiplex Array
28 Nov 2012







